pyrvinium has been researched along with Breast Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, MH; Huang, SW; Lee, WS; Lee, YT; Lin, FH; Su, YS; Sun, JS; Sun, MT; Tzeng, SC; Wang, YC; Wu, TY; Yang, YS | 1 |
| Atkinson, RL; Debeb, BG; Hang, BI; Klopp, AH; Krishnamurthy, S; Lacerda, L; Lee, E; Li, L; McMurray, JS; Orton, D; Reuben, JM; Solley, TN; Ueno, NT; Woodward, WA; Xu, W | 1 |
| Fei, X; Hu, C; Liang, S; Xu, L; Yan, N; Zhang, F; Zhang, L; Zhang, Y | 1 |
| Amoreo, CA; Aria, V; Avvedimento, VE; Bardelli, A; Bosotti, R; Cardone, L; Carrella, D; Ciolli, L; Dattilo, R; di Bernardo, D; Iezzi, M; Isacchi, A; Loreni, F; Manni, I; Mottolese, M; Mutarelli, M; Papaccio, F; Sirci, F; Tumaini, B | 1 |
4 other study(ies) available for pyrvinium and Breast Cancer
| Article | Year |
|---|---|
Cancer as an infectious disease: A different treatment alternative using a combination of tigecycline and pyrvinium pamoate - An example of breast cancer.
Topics: Breast Neoplasms; Communicable Diseases; Female; Humans; Pyrvinium Compounds; Tigecycline | 2022 |
The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice; Mice, Nude; Mice, SCID; Neoplastic Stem Cells; Pyrvinium Compounds; Radiation Tolerance; Radiation-Sensitizing Agents; Spheroids, Cellular; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2013 |
WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; CD24 Antigen; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Humans; Hyaluronan Receptors; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Polymerase Chain Reaction; Pyrvinium Compounds; Wnt Signaling Pathway | 2016 |
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Computational Biology; Drug Approval; Drug Repositioning; Female; Humans; Mammary Glands, Animal; Mice; Niclosamide; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrvinium Compounds; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction | 2016 |